Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
BCL2 1件: BCL2 💬
|
Obatoclax mesylate Obatoclax mesylate 💬
| Obatoclax | 060 1件: 60 💬
|
| 2 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
BCL2 1件: BCL2 💬
|
Venetoclax Venetoclax 💬
| Venetoclax | 028 2件: 28, 85 💬
|
| 3 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CASP9 1件: CASP9 💬
|
Rimiducid Rimiducid 💬
| Rimiducid | 019 7件: 19, 49, 60, 65, 284, 285, 326 💬
|
| 4 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CD19 1件: CD19 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 5 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CD19 1件: CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 6件: 11, 13, 46, 49, 51, 300 💬
|
| 6 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CD19 1件: CD19 💬
|
Obecabtagene autoleucel Obecabtagene autoleucel 💬
| Obecabtagene autoleucel | 049 1件: 49 💬
|
| 7 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CD19 1件: CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 013 4件: 13, 49, 61, 300 💬
|
| 8 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CD19 1件: CD19 💬
|
Tafasitamab Tafasitamab 💬
| Tafasitamab | 051 1件: 51 💬
|
| 9 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CDK4 2件: CDK4, CDK6 💬
|
Abemaciclib Abemaciclib 💬
| Abemaciclib | 034 1件: 34 💬
|
| 10 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Atropine Atropine 💬
| Atropine | 299 1件: 299 💬
|
| 11 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Atropine sulfate Atropine sulfate 💬
| Atropine | 299 1件: 299 💬
|
| 12 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Bethanechol chloride Bethanechol chloride 💬
| Bethanechol | 098 1件: 98 💬
|
| 13 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Blarcamesine Blarcamesine 💬
| Blarcamesine | 006 2件: 6 , 156 💬
|
| 14 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬
| Blarcamesine | 006 2件: 6 , 156 💬
|
| 15 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Chlorpromazine Chlorpromazine 💬
| Chlorpromazine | 254 1件: 254 💬
|
| 16 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Chlorpromazine hydrochloride Chlorpromazine hydrochloride 💬
| Chlorpromazine | 254 1件: 254 💬
|
| 17 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Glycopyrronium tosylate Glycopyrronium tosylate 💬
| Glycopyrronium | 006 2件: 6 , 34 💬
|
| 18 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Methacholine chloride Methacholine chloride 💬
| Methacholine | 096 1件: 96 💬
|
| 19 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Oxybutynin Oxybutynin 💬
| Oxybutynin | 006 3件: 6 , 13, 53 💬
|
| 20 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Oxybutynin chloride Oxybutynin chloride 💬
| Oxybutynin | 006 3件: 6 , 13, 53 💬
|
| 21 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Propantheline bromide Propantheline bromide 💬
| Propantheline | 026 1件: 26 💬
|
| 22 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Propiverine hydrochloride Propiverine hydrochloride 💬
| Propiverine | 226 1件: 226 💬
|
| 23 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Propiverine Propiverine 💬
| Propiverine | 226 1件: 226 💬
|
| 24 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Rocuronium bromide Rocuronium bromide 💬
| Rocuronium | 070 2件: 70, 296 💬
|
| 25 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Scopolamine Scopolamine 💬
| Scopolamine | 002 1件: 2 💬
|
| 26 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Trihexyphenidyl hydrochloride Trihexyphenidyl hydrochloride 💬
| Trihexyphenidyl | 005 2件: 5 , 6 💬
|
| 27 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Trihexyphenidyl Trihexyphenidyl 💬
| Trihexyphenidyl | 005 2件: 5 , 6 💬
|
| 28 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 2件: CHRM1, CHRM2 💬
|
Tropicamide Tropicamide 💬
| Tropicamide | 019 1件: 19 💬
|
| 29 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM2 1件: CHRM2 💬
|
Fesoterodine Fesoterodine 💬
| Fesoterodine | 006 1件: 6 💬
|
| 30 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM2 1件: CHRM2 💬
|
Fesoterodine fumarate Fesoterodine fumarate 💬
| Fesoterodine | 006 1件: 6 💬
|
| 31 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM2 1件: CHRM2 💬
|
Pilocarpine Pilocarpine 💬
| Pilocarpine | 006 3件: 6 , 53, 299 💬
|
| 32 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM2 1件: CHRM2 💬
|
Pilocarpine hydrochloride Pilocarpine hydrochloride 💬
| Pilocarpine | 006 3件: 6 , 53, 299 💬
|
| 33 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM2 1件: CHRM2 💬
|
Pilocarpine nitrate Pilocarpine nitrate 💬
| Pilocarpine | 006 3件: 6 , 53, 299 💬
|
| 34 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CSF1R 1件: CSF1R 💬
|
Axatilimab Axatilimab 💬
| Axatilimab | 085 1件: 85 💬
|
| 35 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CSF1R 9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬
|
Sunitinib malate Sunitinib malate 💬
| Sunitinib | 028 2件: 28, 34 💬
|
| 36 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CSF1R 9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬
|
Sunitinib Sunitinib 💬
| Sunitinib | 028 2件: 28, 34 💬
|
| 37 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CSF3R 1件: CSF3R 💬
|
Filgrastim Filgrastim 💬
| Filgrastim | 002 29件: 2 , 6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 38 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CSF3R 1件: CSF3R 💬
|
Lenograstim Lenograstim 💬
| Lenograstim | 002 8件: 2 , 13, 16, 18, 19, 57, 65, 97 💬
|
| 39 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CSF3R 1件: CSF3R 💬
|
Pegfilgrastim Pegfilgrastim 💬
| Pegfilgrastim | 060 1件: 60 💬
|
| 40 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 1件: EGFR 💬
|
Cetuximab Cetuximab 💬
| Cetuximab | 034 5件: 34, 51, 86, 89, 331 💬
|
| 41 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 1件: EGFR 💬
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬
| Erlotinib | 094 2件: 94, 160 💬
|
| 42 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 1件: EGFR 💬
|
Erlotinib Erlotinib 💬
| Erlotinib | 094 2件: 94, 160 💬
|
| 43 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 1件: EGFR 💬
|
Gefitinib Gefitinib 💬
| Gefitinib | 075 1件: 75 💬
|
| 44 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 1件: EGFR 💬
|
Icotinib Icotinib 💬
| Icotinib | 034 1件: 34 💬
|
| 45 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 2件: EGFR, ERBB2 💬
|
Lapatinib ditosylate Lapatinib ditosylate 💬
| Lapatinib | 034 3件: 34, 74, 75 💬
|
| 46 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 2件: EGFR, ERBB2 💬
|
Lapatinib Lapatinib 💬
| Lapatinib | 034 3件: 34, 74, 75 💬
|
| 47 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 3件: EGFR, ERBB2, ERBB4 💬
|
Afatinib Afatinib 💬
| Afatinib | 285 1件: 285 💬
|
| 48 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 3件: EGFR, ERBB2, ERBB4 💬
|
Afatinib dimaleate Afatinib dimaleate 💬
| Afatinib | 285 1件: 285 💬
|
| 49 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 3件: EGFR, ERBB2, ERBB4 💬
|
Neratinib Neratinib 💬
| Neratinib | 034 1件: 34 💬
|
| 50 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 3件: EGFR, ERBB2, ERBB4 💬
|
Neratinib maleate Neratinib maleate 💬
| Neratinib | 034 1件: 34 💬
|
| 51 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR 4件: EGFR, ERBB2, FLT4, KDR 💬
|
Tesevatinib Tesevatinib 💬
| Tesevatinib | 067 1件: 67 💬
|
| 52 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPHA2 3件: EPHA2, KIT, PDGFRB 💬
|
Dasatinib Dasatinib 💬
| Dasatinib | 051 2件: 51, 85 💬
|
| 53 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPHA2 3件: EPHA2, KIT, PDGFRB 💬
|
Dasatinib Dasatinib 💬
| Dasatinib | 051 2件: 51, 85 💬
|
| 54 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPOR 1件: EPOR 💬
|
Epoetin beta Epoetin beta 💬
| Epoetin beta | 013 2件: 13, 18 💬
|
| 55 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPOR 1件: EPOR 💬
|
Epoetin alfa Epoetin alfa 💬
| Erythropoietin | 002 11件: 2 , 6 , 13, 18, 22, 46, 47, 61, 70, 95, 96 💬
|
| 56 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPOR 1件: EPOR 💬
|
Epoetin epsilon Epoetin epsilon 💬
| Erythropoietin | 002 11件: 2 , 6 , 13, 18, 22, 46, 47, 61, 70, 95, 96 💬
|
| 57 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPOR 1件: EPOR 💬
|
Epoetin theta Epoetin theta 💬
| Erythropoietin | 002 11件: 2 , 6 , 13, 18, 22, 46, 47, 61, 70, 95, 96 💬
|
| 58 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPOR 1件: EPOR 💬
|
Epoetin zeta Epoetin zeta 💬
| Erythropoietin | 002 11件: 2 , 6 , 13, 18, 22, 46, 47, 61, 70, 95, 96 💬
|
| 59 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPOR 1件: EPOR 💬
|
Peginesatide Peginesatide 💬
| Peginesatide | 283 1件: 283 💬
|
| 60 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EPOR 1件: EPOR 💬
|
Peginesatide acetate Peginesatide acetate 💬
| Peginesatide | 283 1件: 283 💬
|
| 61 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGF19 1件: FGF19 💬
|
Aldafermin Aldafermin 💬
| Aldafermin | 094 1件: 94 💬
|
| 62 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGF23 1件: FGF23 💬
|
Burosumab Burosumab 💬
| Burosumab | 238 1件: 238 💬
|
| 63 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 64 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 1件: 276 💬
|
| 65 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGFR1 10件: FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 1件: 85 💬
|
| 66 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 7件: 51, 84, 85, 89, 227, 228, 331 💬
|
| 67 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 7件: 51, 84, 85, 89, 227, 228, 331 💬
|
| 68 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 6件: 13, 36, 38, 39, 65, 96 💬
|
| 69 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FGFR3 1件: FGFR3 💬
|
Recifercept Recifercept 💬
| Recifercept | 276 1件: 276 💬
|
| 70 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FLT1 3件: FLT1, FLT4, KDR 💬
|
Axitinib Axitinib 💬
| Axitinib | 034 1件: 34 💬
|
| 71 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FLT1 3件: FLT1, FLT4, KDR 💬
|
Cediranib Cediranib 💬
| Cediranib | 034 1件: 34 💬
|
| 72 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FLT1 3件: FLT1, FLT4, KDR 💬
|
Cediranib maleate Cediranib maleate 💬
| Cediranib | 034 1件: 34 💬
|
| 73 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FLT1 6件: FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬
|
Pazopanib hydrochloride Pazopanib hydrochloride 💬
| Pazopanib | 227 1件: 227 💬
|
| 74 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FLT3 7件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 2件: 34, 86 💬
|
| 75 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FLT3 7件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 2件: 34, 86 💬
|
| 76 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
FLT3 2件: FLT3, JAK2 💬
|
Pacritinib Pacritinib 💬
| Pacritinib | 331 1件: 331 💬
|
| 77 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
GHR 1件: GHR 💬
|
Pegvisomant Pegvisomant 💬
| Pegvisomant | 077 2件: 77, 265 💬
|
| 78 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
GHR 1件: GHR 💬
|
Somapacitan Somapacitan 💬
| Somapacitan | 195 1件: 195 💬
|
| 79 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
GHR 1件: GHR 💬
|
Somatropin Somatropin 💬
| Somatotropin | 002 28件: 2 , 3 , 13, 19, 36, 46, 65, 74, 75, 76, 77, 78, 96, 97, 107, 113, 156, 187, 191, 193, 195, 238, 246, 265, 274, 276, 299, 337 💬
|
| 80 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
GHR 2件: GHR, IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 4件: 96, 168, 265, 299 💬
|
| 81 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
GHR 2件: GHR, IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 4件: 96, 168, 265, 299 💬
|
| 82 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNA 13件: IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 83 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNA 13件: IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 84 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Anifrolumab Anifrolumab 💬
| Anifrolumab | 046 5件: 46, 49, 50, 51, 53 💬
|
| 85 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon beta Interferon beta 💬
| Human interferon beta | 013 5件: 13, 20, 50, 96, 97 💬
|
| 86 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon alfa Interferon alfa 💬
| Interferon alfa | 025 2件: 25, 56 💬
|
| 87 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon alfa-2a Interferon alfa-2a 💬
| Interferon alfa-2a | 056 1件: 56 💬
|
| 88 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon alfa-2b Interferon alfa-2b 💬
| Interferon alfa-2b | 025 1件: 25 💬
|
| 89 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon beta-1a Interferon beta-1a 💬
| Interferon beta-1a | 013 3件: 13, 96, 97 💬
|
| 90 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon beta-1b Interferon beta-1b 💬
| Interferon beta-1b | 013 1件: 13 💬
|
| 91 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Peginterferon alfa-2a Peginterferon alfa-2a 💬
| Peginterferon alfa-2a | 222 1件: 222 💬
|
| 92 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Peginterferon beta-1a Peginterferon beta-1a 💬
| Peginterferon beta-1a | 013 1件: 13 💬
|
| 93 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IFNB 1件: IFNB 💬
|
Dazukibart Dazukibart 💬
| Dazukibart | 050 1件: 50 💬
|
| 94 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IGF1R 1件: IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 1件: 232 💬
|
| 95 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL2RA 1件: IL2RA 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 96 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL2RA 1件: IL2RA 💬
|
Basiliximab Basiliximab 💬
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
| 97 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL2RA 1件: IL2RA 💬
|
Daclizumab Daclizumab 💬
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬
|
| 98 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬
|
Aldesleukin Aldesleukin 💬
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬
|
| 99 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL4R 1件: IL4R 💬
|
Dupilumab Dupilumab 💬
| Dupilumab | 051 5件: 51, 97, 98, 160, 162 💬
|
| 100 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6 1件: IL6 💬
|
Olokizumab Olokizumab 💬
| Olokizumab | 046 2件: 46, 96 💬
|
| 101 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6 1件: IL6 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
| 102 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6 1件: IL6 💬
|
Pomalidomide Pomalidomide 💬
| Pomalidomide | 028 6件: 28, 34, 51, 85, 227, 331 💬
|
| 103 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6 1件: IL6 💬
|
Siltuximab Siltuximab 💬
| Siltuximab | 028 2件: 28, 331 💬
|
| 104 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6 1件: IL6 💬
|
Sirukumab Sirukumab 💬
| Sirukumab | 041 2件: 41, 46 💬
|
| 105 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6R 1件: IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 5件: 41, 46, 84, 107, 271 💬
|
| 106 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6R 1件: IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 4件: 11, 13, 86, 113 💬
|
| 107 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6R 1件: IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
|
| 108 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL7R 1件: IL7R 💬
|
Lusvertikimab Lusvertikimab 💬
| Lusvertikimab | 097 1件: 97 💬
|
| 109 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
INSR 1件: INSR 💬
|
Insulin detemir Insulin detemir 💬
| Insulin detemir | 299 1件: 299 💬
|
| 110 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
INSR 1件: INSR 💬
|
Insulin glargine Insulin glargine 💬
| Insulin glargine | 299 1件: 299 💬
|
| 111 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
INSR 1件: INSR 💬
|
Insulin human Insulin human 💬
| Insulin human | 156 1件: 156 💬
|
| 112 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
INSR 1件: INSR 💬
|
Insulin lispro Insulin lispro 💬
| Insulin lispro | 053 1件: 53 💬
|
| 113 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
| 114 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 5件: 13, 15, 25, 46, 96 💬
|
| 115 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
ITGA4 3件: ITGA4, ITGB1, ITGB7 💬
|
Carotegrast methyl Carotegrast methyl 💬
| Carotegrast methyl | 097 1件: 97 💬
|
| 116 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 117 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 118 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
ITGA5 3件: ITGA5, ITGB1, ITGB6 💬
|
Bexotegrast Bexotegrast 💬
| Bexotegrast | 094 1件: 94 💬
|
| 119 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 120 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 1件: JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 039 2件: 39, 84 💬
|
| 121 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 1件: JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
|
| 122 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 1件: JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 4件: 46, 51, 97, 228 💬
|
| 123 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 1件: JAK1 💬
|
Itacitinib adipate Itacitinib adipate 💬
| Itacitinib | 046 4件: 46, 51, 97, 228 💬
|
| 124 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 1件: JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 10件: 40, 41, 46, 49, 53, 55, 96, 97, 107, 271 💬
|
| 125 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 1件: JAK1 💬
|
Upadacitinib tartrate Upadacitinib tartrate 💬
| Upadacitinib | 040 10件: 40, 41, 46, 49, 53, 55, 96, 97, 107, 271 💬
|
| 126 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 1件: JAK1 💬
|
Upadacitinib hydrate Upadacitinib hydrate 💬
| Upadacitinib | 040 10件: 40, 41, 46, 49, 53, 55, 96, 97, 107, 271 💬
|
| 127 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 128 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 013 6件: 13, 15, 50, 60, 65, 228 💬
|
| 129 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Ruxolitinib phosphate Ruxolitinib phosphate 💬
| Ruxolitinib | 013 6件: 13, 15, 50, 60, 65, 228 💬
|
| 130 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 3件: JAK1, JAK2, JAK3 💬
|
Delgocitinib Delgocitinib 💬
| Delgocitinib | 050 1件: 50 💬
|
| 131 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 3件: JAK1, JAK2, JAK3 💬
|
Filgotinib maleate Filgotinib maleate 💬
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
|
| 132 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 3件: JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 1件: 46 💬
|
| 133 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 3件: JAK1, JAK2, JAK3 💬
|
Tofacitinib citrate Tofacitinib citrate 💬
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 134 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 3件: JAK1, JAK2, JAK3 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 135 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 4件: JAK1, JAK2, JAK3, SYK 💬
|
Gusacitinib Gusacitinib 💬
| Gusacitinib | 049 1件: 49 💬
|
| 136 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK3 1件: JAK3 💬
|
Ritlecitinib tosylate Ritlecitinib tosylate 💬
| Ritlecitinib | 046 3件: 46, 96, 97 💬
|
| 137 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KDR 2件: KDR, MET 💬
|
Cabozantinib Cabozantinib 💬
| Cabozantinib | 034 1件: 34 💬
|
| 138 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KDR 2件: KDR, MET 💬
|
Cabozantinib s-malate Cabozantinib s-malate 💬
| Cabozantinib | 034 1件: 34 💬
|
| 139 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT 1件: KIT 💬
|
Barzolvolimab Barzolvolimab 💬
| Barzolvolimab | 098 1件: 98 💬
|
| 140 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT 1件: KIT 💬
|
Masitinib Masitinib 💬
| Masitinib | 002 6件: 2 , 5 , 6 , 13, 46, 96 💬
|
| 141 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
|
| 142 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib Imatinib 💬
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
|
| 143 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT 3件: KIT, PDGFRA, PDGFRB 💬
|
Nilotinib Nilotinib 💬
| Nilotinib | 006 5件: 6 , 8 , 34, 51, 86 💬
|
| 144 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Binimetinib Binimetinib 💬
| Binimetinib | 034 1件: 34 💬
|
| 145 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Cobimetinib Cobimetinib 💬
| Cobimetinib | 280 1件: 280 💬
|
| 146 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Cobimetinib fumarate Cobimetinib fumarate 💬
| Cobimetinib | 280 1件: 280 💬
|
| 147 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Mirdametinib Mirdametinib 💬
| Mirdametinib | 034 4件: 34, 278, 279, 280 💬
|
| 148 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Selumetinib Selumetinib 💬
| Selumetinib | 034 1件: 34 💬
|
| 149 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Selumetinib sulfate Selumetinib sulfate 💬
| Selumetinib | 034 1件: 34 💬
|
| 150 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Trametinib Trametinib 💬
| Trametinib | 002 6件: 2 , 34, 58, 195, 279, 280 💬
|
| 151 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Trametinib dimethyl sulfoxide Trametinib dimethyl sulfoxide 💬
| Trametinib | 002 6件: 2 , 34, 58, 195, 279, 280 💬
|
| 152 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MTOR 1件: MTOR 💬
|
Everolimus Everolimus 💬
| Everolimus | 034 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
|
| 153 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MTOR 1件: MTOR 💬
|
Sirolimus Sirolimus 💬
| Sirolimus | 002 46件: 2 , 6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 154 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
MTOR 1件: MTOR 💬
|
Temsirolimus Temsirolimus 💬
| Temsirolimus | 013 4件: 13, 34, 89, 331 💬
|
| 155 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
NFKB1 1件: NFKB1 💬
|
Iguratimod Iguratimod 💬
| Iguratimod | 046 6件: 46, 49, 51, 53, 271, 300 💬
|
| 156 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
NGFB 1件: NGFB 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 2件: 226, 298 💬
|
| 157 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
NGFR 1件: NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 1件: 53 💬
|
| 158 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
NOS3 1件: NOS3 💬
|
Tilarginine acetate Tilarginine acetate 💬
| Tilarginine | 067 1件: 67 💬
|
| 159 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
OSMR 1件: OSMR 💬
|
Vixarelimab Vixarelimab 💬
| Vixarelimab | 051 3件: 51, 85, 97 💬
|
| 160 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PDGFRA 2件: PDGFRA, PDGFRB 💬
|
Seralutinib Seralutinib 💬
| Seralutinib | 086 1件: 86 💬
|
| 161 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 162 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PIK3CA_B_D 1件: PIK3CA_B_D 💬
|
Alpelisib Alpelisib 💬
| Alpelisib | 138 4件: 138, 278, 279, 280 💬
|
| 163 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PIK3CA_B_D 1件: PIK3CA_B_D 💬
|
Leniolisib phosphate Leniolisib phosphate 💬
| Leniolisib | 053 2件: 53, 65 💬
|
| 164 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PIK3CA_B_D 1件: PIK3CA_B_D 💬
|
Parsaclisib Parsaclisib 💬
| Parsaclisib | 035 3件: 35, 53, 61 💬
|
| 165 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PIK3CA_B_D 2件: PIK3CA_B_D, PIK3CA_B_D 💬
|
Copanlisib Copanlisib 💬
| Copanlisib | 121 1件: 121 💬
|
| 166 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PIK3CA_B_D 3件: PIK3CA_B_D, PIK3CA_B_D, PIK3CA_B_D 💬
|
Leniolisib Leniolisib 💬
| Leniolisib | 053 2件: 53, 65 💬
|
| 167 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PRKAA 2件: PRKAA, PRKAA 💬
|
Metformin hydrochloride Metformin hydrochloride 💬
| Metformin | 002 28件: 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬
|
| 168 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PRKAA 2件: PRKAA, PRKAA 💬
|
Metformin Metformin 💬
| Metformin | 002 28件: 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬
|
| 169 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PRL 1件: PRL 💬
|
Bromocriptine mesylate Bromocriptine mesylate 💬
| Bromocriptine | 006 2件: 6 , 74 💬
|
| 170 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PRL 1件: PRL 💬
|
Bromocriptine Bromocriptine 💬
| Bromocriptine | 006 2件: 6 , 74 💬
|
| 171 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PRL 1件: PRL 💬
|
Cabergoline Cabergoline 💬
| Cabergoline | 006 4件: 6 , 74, 75, 77 💬
|
| 172 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PRL 1件: PRL 💬
|
Terguride Terguride 💬
| Terguride | 051 2件: 51, 86 💬
|
| 173 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
RELA 1件: RELA 💬
|
Edasalonexent Edasalonexent 💬
| Edasalonexent | 113 1件: 113 💬
|
| 174 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
RXRA 1件: RXRA 💬
|
Acitretin Acitretin 💬
| Acitretin | 037 1件: 37 💬
|
| 175 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
RXRA 1件: RXRA 💬
|
Alitretinoin Alitretinoin 💬
| Alitretinoin | 049 1件: 49 💬
|
| 176 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
RXRA 1件: RXRA 💬
|
Bexarotene Bexarotene 💬
| Bexarotene | 013 2件: 13, 75 💬
|
| 177 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
SYK 1件: SYK 💬
|
Fostamatinib Fostamatinib 💬
| Fostamatinib | 046 5件: 46, 49, 61, 63, 66 💬
|
| 178 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
SYK 1件: SYK 💬
|
Fostamatinib disodium Fostamatinib disodium 💬
| Fostamatinib | 046 5件: 46, 49, 61, 63, 66 💬
|
| 179 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
|
| 180 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 181 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
VWF 1件: VWF 💬
|
Caplacizumab Caplacizumab 💬
| Caplacizumab | 063 2件: 63, 64 💬
|